STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
45 hedge funds and large institutions have $108M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
79% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 19
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
45
Holding in Top 10
–
Calls
$87K
Puts
$259K
Top Buyers
| 1 | +$666K | |
| 2 | +$616K | |
| 3 | +$579K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$514K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$255K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$832K | |
| 3 | -$776K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$719K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$495K |